The Interface of Neurology & Internal Medicine

by Biller, José

• ISBN13: 9780781779067
• ISBN10: 0781779065
• Edition: 1st
• Format: Hardcover
• Copyright: 2007-09-12
• Publisher: LWW

Summary

This book is the first comprehensive reference on the interface between neurology and internal medicine. In 171 chapters organized by organ system, the book examines the neurologic manifestations of dozens of medical conditions, the neurologic effects of drugs, organ transplantation, and other treatments, and the medical comorbidities or complicationsiatrogenic or otherwisethat neurologists must diagnose and treat in patients with neurologic disease. Most chapters are co-authored by a neurologist and a non-neurologic specialist. Each chapter presents information in an accessible format and includes a case vignette and the authors' recommendations for the case. A companion Website provides a multiple-choice question for each chapter and the fully searchable text, with case vignettes and recommendations linked.

Table of Contents

Cardiac manifestations of neurological disorders	p. 1
Neurologic manifestations of congenital heart disease	p. 8
Acquired valvular heart disease	p. 17
Infective endocarditis	p. 26
Coronary artery disease	p. 33
Heart failure	p. 40
Cardiomyopathies and other myocardial diseases	p. 50
Cardiac arrhythmias	p. 61
Hypertension and hypertensive encephalopathy	p. 67
Orthostatic and postprandial hypotension	p. 72
Coronary artery bypass surgery	p. 81
Other cardiovascular surgical/endovascular procedures	p. 86
Atrial myxomas	p. 90
Neurological sequelae of cardiac transplantation	p. 93
Aortic diseases	p. 99
Commonly used cardiovascular drugs	p. 109
Acute and chronic respiratory failure	p. 113
Chronic obstructive pulmonary disease	p. 121
Pulmonary/pleural infections	p. 126
Venous thromboembolism	p. 131
Lung cancer	p. 139
Sleep apnea syndromes and other sleep-related breathing disorders	p. 151
Neurologic manifestations of interstitial lung disease	p. 158
Lung transplantation	p. 163
Pharmacology of respiratory diseases	p. 169
Acute renal failure	p. 175
Chronic renal failure	p. 180
Glomerular diseases	p. 185
Vascular diseases of the kidney	p. 192
Dialysis	p. 198
Renal transplantation	p. 205
Commonly used renal drugs	p. 211
Esophageal disorders and surgery	p. 217
Diseases of the stomach and duodenum	p. 222
Inflammatory bowel disease	p. 228
Neurologic manifestations of gluten sensitivity	p. 233
Diseases of the pancreas	p. 238
Neurologic complications of gastrointestinal malignancies	p. 245
Bariatric surgery	p. 250
Gastrointestinal transplantation	p. 256
Commonly used gastrointestinal drugs	p. 259
Neurological problems seen during the management of the patient with viral hepatitis	p. 265
Management of acute liver failure : emphasis on neurologic complications	p. 274
Hepatic encephalopathy	p. 281
Liver transplantation	p. 290
Commonly used liver drugs	p. 295
Red blood cell disorders	p. 301
Disorders of white blood cells	p. 310
Disorders of platelets	p. 318
Sickle cell anemia and other hemoglobinopathies	p. 323
Bleeding diatheses and hemophilias	p. 329
Thrombotic disorders	p. 336
Lymphoproliferative disorders	p. 341
Plasma cell disorders	p. 347
Bone marrow transplantation	p. 352
Commonly used hematologic drugs	p. 357
Paraneoplastic disorders of the central nervous system	p. 363
Paraneoplastic disorders of the peripheral nervous system	p. 370
Radiation therapy in neurologic disease	p. 377
Chemotherapy	p. 387
Disorders of carbohydrate metabolism	p. 393
Disorders of lipoprotein metabolism	p. 399
Disorders of amino acid metabolism	p. 404
Disorders of the metabolism of purines and pyrimidines	p. 410
Disorders of porphyrins	p. 415
Disorders of heavy metals	p. 422
Disorders of bone and bone mineral metabolism	p. 427
Paget disease of bone	p. 434
Nutritional deficiency syndromes	p. 439
Hydrosoluble vitamins (except B[subscript 12] and folate)	p. 443
Fat soluble vitamins	p. 449
Cobalamin (B[subscript 12]) deficiency	p. 453
Folic acid deficiency	p. 456
Parenteral nutrition and neurologic complications	p. 459
Enteral nutrition	p. 462
Pituitary and hypothalamus	p. 465
Thyroid dysfunction	p. 471
Neurologic complications of parathyroid gland disorders : hypoparathyroidism and hyperparathyroidism	p. 476
Disorders of the adrenal glands and neuroendocrine tumors	p. 482
Diabetes mellitus	p. 497
Testis and ovaries	p. 502
Multiple endocrine syndromes	p. 508
Commonly used endocrine drugs	p. 511
Rheumatoid arthritis, spondyloarthropathies and relapsing polychondritis	p. 519
Systemic lupus erythematosus, Sjogren's syndrome, and scleroderma	p. 524
Primary vasculitides and the nervous system	p. 529
Inflammatory myopathies	p. 534
Heritable connective tissue diseases	p. 538
Spinal stenosis	p. 546
Bone tumors	p. 550
Commonly used drugs (COX-2 inhibitors, NSAID, corticosteroids)	p. 555
Bacterial meningitis	p. 559
Stroke complicating systemic and central nervous system infections	p. 564
Hiv/Aids	p. 571
Fungal infections of the central nervous system	p. 577
Rickettsia	p. 583
Protozoa and metazoa	p. 590
Syphilis	p. 598
Lyme disease	p. 604
Tuberculosis	p. 611
Malaria	p. 616
Other topical infections	p. 621
Common antibiotics	p. 629
Opiates	p. 635
Amphetamines and over-the-counter sympathomimetics	p. 642
Cocaine	p. 650
Hallucinogens	p. 654
Alcohol	p. 660
Solvents	p. 666
Marijuana	p. 671
PCP/ketamine	p. 674
Other intoxicants	p. 679
Hypothermia	p. 683
Hyperthermia	p. 690
Disorders associated with diving, decompression, and gas bubbles	p. 695
Drowning	p. 702
Carbon monoxide poisoning	p. 707
The evaluation and management of lightning injuries	p. 711
High altitude illness	p. 716
Ciguatera poisoning	p. 723
Venomous snakebites in the US	p. 727
Skin neoplasms	p. 731
Phakodermatoses and other genetic conditions with dermatologic manifestations	p. 739
Neuro-dermatological presentations of systemic illness	p. 749
Commonly used dermatological drugs	p. 755
Coma (non-traumatic) and brain death	p. 763
Shock	p. 767
Sepsis	p. 774
Mechanical ventilation	p. 781
Acid-base disorders	p. 786
Fluid and electrolyte disorders	p. 791
Hemodynamic control : pressors and antihypertensive agents	p. 797
Sedation and analgesia in the neurological intensive care unit	p. 803
Critical illness polyneuropathy and myopathy	p. 809
ICU psychosis	p. 813
Orbital diseases	p. 819
Ocular infections and inflammation	p. 823
Optic neuritis and retinal vascular disorders	p. 827
Head, neck, and skull base neoplasms	p. 831
ENT infections and inflammation	p. 835
Vertigo	p. 839
Preeclampsia and eclampsia	p. 843
Headaches in pregnancy	p. 848
Epilepsy in pregnancy	p. 853
Teratogenicity of antiepileptic drugs	p. 858
Pregnancy-related neuropathies	p. 862
Movement disorders in pregnancy	p. 867
Diphtheria	p. 871
Pertussis	p. 873
Measles	p. 877
Mumps	p. 884
Rubella	p. 886
Varicella-zoster infections	p. 892
Erythema infectiosum (fifth disease)	p. 898
Neurologic complications of Henoch-Schonlein purpura	p. 902
Neurologic complications of the hemolytic uremic syndrome	p. 905
Nonaccidental head trauma in infants : the "shaken baby syndrome"	p. 909
Neurologic complications of cystic fibrosis	p. 914
Neurologic consequences of vaccines in children	p. 918
Acute radiation syndrome	p. 922
Nerve agents	p. 926
Botulinum toxin	p. 933
Cyanide	p. 938
Smallpox	p. 943
Depression and neurology	p. 949
The anxiety disorders : clinical presentation, diagnosis, treatment, and beyond	p. 958
Delirium	p. 965
Somatoform disorders	p. 969
Suicide risk assessment	p. 973
Commonly used psychotropic medications	p. 978
Commonly used drugs in the neurology realm	p. 989
Table of Contents provided by Blackwell. All Rights Reserved.